CLDX
Celldex Therapeutics Inc
38.20$
-1.9%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 94.8% | 73.2% | 1,503.5% | 754.7% | 696.7% | 1,194.3% | 573.4% | 1,146.2% | 3,489.9% | 1,714.5% | 2,329.8% | – | |
| 5.2% | 26.8% | -1,403.5% | -654.7% | -596.7% | -1,094.3% | -473.4% | -1,046.2% | -3,389.9% | -1,614.5% | -2,229.8% | 100.0% | |
| 2,910.8% | 1,827.9% | 1,513.8% | 754.7% | 696.7% | 1,194.3% | 546.4% | 1,221.5% | 3,489.9% | 1,714.5% | 2,329.8% | 16,340.0% | |
| 575.1% | 617.5% | 530.2% | 196.2% | 202.0% | 431.7% | 194.9% | 440.5% | 1,153.8% | 449.1% | 549.1% | 2,920.0% | |
| 3,419.3% | 635.9% | 555.2% | 299.0% | 1,043.5% | 445.9% | 380.7% | 485.6% | 1,499.1% | 630.7% | 549.1% | 19,260.0% | |
| -3,414.1% | -2,363.9% | -1,958.7% | -953.7% | -1,640.1% | -1,540.2% | -854.1% | -1,531.8% | -4,889.0% | -2,245.3% | -2,778.9% | -19,160.0% | |
| 0.0% | 0.0% | 0.0% | 125.3% | 1,584.1% | 0.0% | 253.7% | 2.4% | 123.4% | – | – | – | |
| -3,292.8% | -2,321.1% | -1,894.0% | -920.6% | -1,593.1% | -1,424.0% | -821.6% | -1,520.9% | -4,765.6% | -2,054.8% | -2,248.8% | -17,253.3% | |
| -121.3% | -42.8% | -129.3% | -190.6% | -8.0% | -14.2% | -15.7% | -4.9% | 443.7% | 41.3% | -2,248.8% | – | |
| -3,292.8% | -2,321.1% | -1,894.0% | -730.1% | -1,585.1% | -1,424.0% | -805.9% | -1,516.0% | -4,765.6% | -2,054.8% | -2,248.8% | -17,253.3% | |
| -3,198.0% | -2,290.7% | -1,833.7% | -816.3% | -761.2% | -1,390.1% | -615.3% | -1,420.8% | -4,420.9% | -2,020.0% | -2,203.5% | -17,028.0% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.